Evidence map›Paper›PMID 40171519›Full record

ArticleHemaSphere2025

European Cancer Organisation Essential Requirements for Quality Cancer Care: Hematological malignancies.

John G Gribben, Leticia Quintanilla-Martinez, Simon Crompton, Jann Arends, Christophe Bardin, Heiko Becker, Frederic Castinetti, Dégi L Csaba, Melvin D'Anastasi, Thomas Frese and 12 more

Abstract read
In one paragraph

Article in HemaSphere, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

John G GribbenBarts Cancer Institute Queen Mary University London UK.
Leticia Quintanilla-MartinezInstitute of Pathology Neuropathology and Molecular Pathology, University Hospital Tübingen Tübingen Germany.
Simon CromptonEuropean Cancer Organisation Brussels Belgium.ORCID 0000-0002-4623-1192
Jann ArendsFreiburg University Hospital, Department of Medicine I, Medical Center University of Freiburg Freiburg Germany.
Christophe BardinDepartment of Pharmacy Hôpital Cochin AP-HP Centre, Université Paris Cité Paris France.
Heiko BeckerMedical Center, Faculty of Medicine University of Freiburg Freiburg Germany.
Frederic CastinettiAix-Marseille Université Marseille France.
Dégi L CsabaBabeș-Bolyai University, Faculty of Sociology and Social Work Cluj-Napoca Romania.
Melvin D'AnastasiMedical Imaging Department, Mater Dei Hospital University of Malta Msida Malta.
Thomas FreseInstitut of General Practice and Family Medicine, Medical Faculty Martin-Luther-University Halle-Wittenberg Halle Germany.
Jan GeisslerLeukemia Patient Advocates Foundation (LePAF) Bern Switzerland.
Reda MatuzevicieneVilnius University, Faculty of Medicine Vilnius Lithuania.
Marius E MayerhoeferNYU Grossman School of Medicine New York New York USA.
Rui MedeirosPortuguese Oncology Institute of Porto Porto Portugal.
Kate MorganMyeloma Patients Europe (MPE) Brussels Belgium.
Šarūnas NarbutasYouth Cancer Europe (YCE) Cluj-Napoca Romania.
Samantha NierAcute Leukemia Advocates Network (ALAN) Bern Switzerland.
Umberto RicardiDepartment of Oncology University of Turin Turin Italy.
Eugenia Trigoso ArjonaHospital Universitario y Politécnico La Fe Valencia Spain.
Mehmet UnganWONCA Europe Ljubljana Slovenia.
Lorna WarwickLymphoma Coalition Europe (LCE) Mississauga Ontario Canada.
Emanuele ZuccaOncology Institute of Southern Switzerland Bellinzona Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40171519
PMCPMC11956721

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.